The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

IBS - Irritable Bowel Syndrome Clinical Trial

— IBS  

Official title:

The Prevalence of Irritable Bowel Syndrome Using Rome IV Criteria in Medical Student and The Related Factors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03178877
• Other study ID #: 16-11-430
• Status: Completed
• Phase: N/A
• First received: June 3, 2017
• Last updated: June 5, 2017
• Start date: November 1, 2016
• Est. completion date: December 31, 2016

Study information

• Verified date: June 2017
• Source: Indonesia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects.

Description:

A cross-sectional study of 350 medical student Universitas Indonesia from first grade until fifth grade was done during November-December 2016. This study used stratified randomized sampling. The Rome IV criteria was used for diagnosing IBS. Questionnaire-guided interview was applied to all subjects. A bivariate analysis was done to know the relationship between IBS and its related factors using chi-square, unpaired t-test, and their alternatives. Multivariate analysis was done using logistic regression test

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: December 31, 2016
• Est. primary completion date: December 31, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years to 30 Years

Eligibility

Inclusion Criteria:

• Age of participant >= 15 years

• Volunteer to participate in study

Exclusion Criteria:

• Red flag symptoms: febrile, vomiting, rectal bleeding, weight lost

• Diagnosed as having Inflammatory bowel disease

• Peptic ulcer drug consumption

• History of gastrointestinal surgery

Related Conditions & MeSH terms

• IBS - Irritable Bowel Syndrome
• Irritable Bowel Syndrome
• Syndrome

Intervention

Other:
• No intervention

Locations

Country	Name	City	State
Indonesia	Cipto Mangunkusumo Hospital	Jakarta Pusat	DKI Jakarta

Sponsors (1)

Lead Sponsor	Collaborator
Indonesia University

Country where clinical trial is conducted

Indonesia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anxiety and depression	Anxiety and Depression using Hospital Anxiety Depression Scale	1 month
Secondary	Sleep Quality	Sleep quality using Pittsburg Sleep Quality Index	1 month
Secondary	Spiritual status	Spiritual status using Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing	1 month
Secondary	Academic Stress	Academic stress using Student-Life Stress Inventory	6 months